Product Program year 2020 Source: CMS Open Payments

Follistim Aq Pen Device

Biological Womens Health

NDC 0052-0326-01

Open in the dashboard

General payments

$3,228

210 payments

Research payments

$0

0 payments

Through program year 2020, $3,228 in general payments and $0 in research payments were reported against Follistim Aq Pen Device (Womens Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $1,159 74
2019 General $2,069 136

Breakdown

Who paid General payments · program years 2019–2020
  1. Merck Sharp & Dohme Corporation $3,228 210 payments
Top recipients General payments · program year 2020
  1. John Crochet Reproductive Endocrinology · Webster, TX $71 6% · 5 payments
  2. John Storment Reproductive Endocrinology · Lafayette, LA $62 5% · 4 payments
  3. Jerry Sims Reproductive Endocrinology · Webster, TX $54 5% · 4 payments
  4. Heber Dunaway Reproductive Endocrinology · Mandeville, LA $50 4% · 3 payments
  5. Peter Lu Reproductive Endocrinology · Mandeville, LA $50 4% · 3 payments

The top 5 of 45 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Reproductive Endocrinology Obstetrics & Gynecology $843 81% · 35 practitioners
  2. Obstetrics & Gynecology $186 18% · 6 practitioners
  3. Maternal & Fetal Medicine Obstetrics & Gynecology $16 2% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Texas $321 28% · 11 recipients
  2. Louisiana $258 22% · 7 recipients
  3. Illinois $125 11% · 5 recipients
  4. New York $116 10% · 4 recipients
  5. California $63 5% · 4 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

210 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record